Meta-analysis of cryoablation versus radiofrequency ablation in the treatment of malignant liver tumors

References

• European Association for the Study of the Liver. Electronic address: [email protected]; European Association for the Study of the Liver. EASL clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2018;69(1):182–236. Epub 2018 Apr 5. Erratum in: J Hepatol. 2019 Apr;70(4):817. doi: 10.1016/j.jhep.2018.03.019.
   PubMed Web of Science ®Google Scholar
• Brodt P. Role of the microenvironment in liver metastasis: from pre- to prometastatic niches. Clin Cancer Res. 2016;22(24):5971–5982. doi: 10.1158/1078-0432.CCR-16-0460.
   PubMed Web of Science ®Google Scholar
• Hackl C, Neumann P, Gerken M, et al. Treatment of colorectal liver metastases in Germany: a ten-year population-based analysis of 5772 cases of primary colorectal adenocarcinoma. BMC Cancer. 2014;14(1):810. PMID: 25369977; doi: 10.1186/1471-2407-14-810.
   PubMed Web of Science ®Google Scholar
• Li F, Chen F, Li W. Progress in ablation therapy of liver cancer. WCJD. 2017;25(27):2427–2432. doi: 10.11569/wcjd.v25.i27.2427.
   Google Scholar
• Fan WJ. Clinical application and comparative advantage of radiofrequency, microwave and cryoablation for tumor treatment. J Pract Med. 2013;29(21):3447–3448.
   Google Scholar
• Aghayev A, Tatli S. The use of cryoablation in treating liver tumors. Expert Rev Med Devices. 2014;11(1):41–52. Epub 2013 Nov 26. doi: 10.1586/17434440.2014.864551.
   PubMed Web of Science ®Google Scholar
• Liang Z, Zhixian C, Zhongbao P, et al. Ultrasound -guided percutaneous microwave ablation versus cryoablation for treatment of hepatocellular carcinoma on the high-risk location. Chin J Inter Rad. 2019;7(03):190–196.
   Google Scholar
• Higgins JP, Altman DG, Gøtzsche PC, Cochrane Bias Methods Group. Cochrane Statistical Methods Group., et al. The cochrane collaboration’s tool for assessing risk of bias in randomised trials. BMJ. 2011;343(oct18 2):d5928–d5928. doi: 10.1136/bmj.d5928.
   PubMed Web of Science ®Google Scholar
• Wells GA, Shea BJ, O’Connell D, et al. The Newcastle–Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. https://www.ohri.ca/programs/clinical_epidemiology/oxford.htm. Accessed 5 Nov 2019
   Google Scholar
• Wang C, Wang H, Yang W, et al. Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology. 2015; 61(5):1579–1590. doi: 10.1002/hep.27548.
   PubMed Web of Science ®Google Scholar
• Adam R, Hagopian EJ, Linhares M, et al. A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. Arch Surg. 2002; 137(12):1332–1339; discussion 1340. discussion 1340. doi: 10.1001/archsurg.137.12.1332.
   PubMedGoogle Scholar
• Cha SY, Kang TW, Min JH, et al. RF ablation versus cryoablation for small perivascular hepatocellular carcinoma: Propensity score analyses of Mid-Term outcomes. Cardiovasc Intervent Radiol. 2020; 43(3):434–444. Epub 2019 Dec 16. doi: 10.1007/s00270-019-02394-4.
   PubMed Web of Science ®Google Scholar
• Dunne RM, Shyn PB, Sung JC, et al. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: a comparison of the safety of cryoablation and radiofrequency ablation. Eur J Radiol. 2014;83(4):632–638. Epub 2014 Jan 18. doi: 10.1016/j.ejrad.2014.01.007.
   PubMed Web of Science ®Google Scholar
• Ko SE, Lee MW, Rhim H, et al. Comparison of procedure-related complications between percutaneous cryoablation and radiofrequency ablation for treating periductal hepatocellular carcinoma. Int J Hyperthermia. 2020;37(1):1354–1361. doi: 10.1080/02656736.2020.1849824.
   PubMed Web of Science ®Google Scholar
• Jie L, Wenzhi G, Yongfu Z, et al. Efficacy comparison of high-intensity focused ultrasound, argon-helium cryoablation and radiofrequency ablation in treatment of small liver cancer. Chin J Hepat Surg. 2019;8(02):133–138.
   Google Scholar
• Lijie S, Peng Y, Juanna Z, et al. Comparative analysis of liver cancer treatment effect by using Ar-He eryablation, radiofrequency radiation and microwave ablation. J Med Imaging. 2015;25(10):1836–1839.
   Google Scholar
• Pan JS, Ou B, Wang HH, et al. Clinical application of argon helium cryoablation and radiofrequency ablation in the treatment of liver cancer. Lingnan Modern Clinics in Surgery. 2018;18(06):624–626.
   Google Scholar
• Pearson AS, Izzo F, Fleming RY, et al. Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178(6):592–599. doi: 10.1016/s0002-9610(99)00234-2.
   PubMed Web of Science ®Google Scholar
• Shen LJ. Comparative analysis of treatment effect of primary hepatic carcinoma (PHC) by applying Ar-He cryoablation and radiofrequency radiation. J Med Imaging. 2015;25(07):1216–1220.
   Google Scholar
• Cucchetti A, Piscaglia F, Cescon M, et al. Systematic review of surgical resection vs radiofrequency ablation for hepatocellular carcinoma. World J Gastroenterol. 2013;19(26):4106–4118. doi: 10.3748/wjg.v19.i26.4106.
   PubMed Web of Science ®Google Scholar
• Littrup PJ, Aoun HD, Adam B, et al. Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series. Abdom Radiol (NY). 2016; 41(4):767–780. doi: 10.1007/s00261-016-0687-x.
   PubMed Web of Science ®Google Scholar
• Bilchik AJ, Wood TF, Allegra D, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg. 2000;135(6):657–662. doi: 10.1001/archsurg.135.6.657.
   PubMedGoogle Scholar
• Sohn RL, Carlin AM, Steffes C, et al. The extent of cryosurgery increases the complication rate after hepatic cryoablation. Am Surg. 2003;69(4):317–323. doi: 10.1177/000313480306900408.
   PubMed Web of Science ®Google Scholar